MARGUARETTE SUPRIEN: Open Payments
NPI 1881051415 · N LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $121 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $174 |
| KYOWA KIRIN, INC. | 1 | $122 |
| Janssen Pharmaceuticals, Inc | 1 | $95 |
| Sage Therapeutics, LLC | 2 | $47 |
Products named: CAPLYTA, Vemlidy, INVEGA SUSTENNA, ZURZUVAE.
Industry payments across NV — which companies pay providers there.
